ICARES Medicus, Inc.

6612

TW0006612005

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
133 ^TWD	-2.92%		-3.27%	+5.56%

Mar. 14	ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	ICARES Medicus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

ICARES Medicus, Inc.(TPEX:6612) added to S&P Global BMI Index

September 18, 2023 at 12:00 am EDT

Latest news about ICARES Medicus, Inc.

ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
ICARES Medicus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10	CI
ICARES Medicus, Inc.(TPEX:6612) added to S&P Global BMI Index	23-09-18	CI
ICARES Medicus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
ICARES Medicus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-19	CI
ICARES Medicus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-13	CI
ICARES Medicus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-09	CI
ICARES Medicus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-10	CI
ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-21	CI
ICARES Medicus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-11	CI
Icares Medicus, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-11	CI
Icares Medicus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-13	CI
Icares Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-18	CI
Icares Medicus, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-05	CI
Icares Medicus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-11	CI
Icares Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-15	CI
Icares Medicus, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-07	CI
Icares Medicus, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-11	CI
Icares Medicus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-09	CI
ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-17	CI

Icares Medicus Inc is a Taiwan-based company mainly engaged in the authorization of high-end medical material surface treatment technology. The Company is also involved in the sale of surface treatment formulations and provision of customer surface treatment processing services, as well as the research and development, manufacture and sale of artificial lens and its implantation system. The Company's product revenue is mainly divided into three categories. The royalty income comes from the authorization of implantation/invasive high-end medical material surface treatment technology. The technical service income mainly includes implantation/invasive high-end medical surface treatment services, provision of medical coatings and foundry of artificial lens implantation systems. The sales of medical materials mainly include the sales of medical materials surface inspection equipment and other products. The Company distributes its products in domestic and overseas markets.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ICARES MEDICUS, INC.	+5.56%	160M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B